Ryan Wilcox

Professor of Internal Medicine and Program Director · University of Michigan

Credentials: · · · · · · ·

History

Novel Multi-Targeted Strategies Targeting T-Cell Lymphomas and Their Microenvironment
National Cancer Institute · R01
Contact PI · $646.9K · University of Michigan at Ann Arbor
2026–2031
Notch Ligands as Oncogenic Drivers and Therapeutic Targets in T-Cell Lymphomas
National Cancer Institute · R01
Contact PI · $1.9M · University of Michigan at Ann Arbor
2024–2028
Novel Therapeutic Strategies Targeting the Enhancer Landscape in High-Risk T-Cell Lymphomas.
National Cancer Institute · R21
Contact PI · $401.1K · University of Michigan at Ann Arbor
2026–2028
University of Michigan Rogel Cancer Center Support Grant 2023-2028
National Cancer Institute · P30
Project lead · $520.4K · University of Michigan at Ann Arbor
1997–2028

Phase 1 Trial of ST-001 nanoFenretinide in Relapsed/Refractory T-cell Non-Hodgkin Lymphoma
Principal investigator · Recruiting · Phase 1
SciTech Development, Inc.
2023–2027
Pembrolizumab and Mogamulizumab in Advanced-stage, Relapsed/Refractory Cutaneous T-cell Lymphomas
Principal investigator · Recruiting · Phase 2
University of Michigan Rogel Cancer Center
2023–2027
Pacritinib in Relapsed/Refractory T-cell Lymphoproliferative Neoplasms
Principal investigator · Recruiting · Phase 2
University of Michigan Rogel Cancer Center
2023–2028
Pacritinib in Relapsed/Refractory Lymphoproliferative Disorders
Principal investigator · Terminated · Phase 1
University of Michigan Rogel Cancer Center
2019–2020